Login · Contact

Akorn Pharmaceuticals

 
Akorn Investor Relations
Stock Information
 symbol  AKRX  open   37.99   change   +1.14 
 last price   39.18   high   39.26   time  4:00pm
 date   11/26/2014   low   37.92   volume   723711 

Stock price delayed 20 min, Time shown is time of last trade
Corporate Profile

Akorn, Inc. is a niche pharmaceutical company that develops, manufactures, and markets generic, branded prescription, animal health, and consumer health products. We specialize in difficult-to-manufacture alternate sterile and non-sterile dosage forms including: ophthalmics, injectables, oral liquids, oral solids, otics, topicals, inhalations, and nasal sprays.

Akorn has fully dedicated Research and Development facilities in Vernon Hills, IL; Warminster, PA; and Copiague, NY that insure a robust and continuous pipeline of new products. In 2014, the Company completed the acquisition of Hi-Tech Pharmacal Co., Inc. and VersaPharm Inc. further expanding our manufacturing capabilities in our Decatur, IL; Somerset, NJ; Amityville, NY; and Paonta Sahib, India facilities. Akorn markets prodcuts to retail pharmacy chains, ophthalmologists, optometrists, physicians, veterinarians, hospitals, clinics, wholesalers, distributors, group purchasing organizations, and government agencies.


Location - Company Headquarters, Lake Forest, IL, 107 employees, 54 field based employees - Distribution Warehouse, Gurnee, IL, 12 employees - Research & Development, Vernon Hills, IL, 26 employees - Injectable Manufacturing, Decatur, IL, 410 employees - Ophthalmics Manufacturing, Somerset, NJ, 152 employees - AVR Headquarters, Ann Arbor, MI, 12 employees - India Headquarters, Gurgaon, India, 12 employees - Sterile Manufacturing, Paonta Sahib, India, 288 employees 1948 - Taylor Pharmacal founded in Decatur, Illinois, 1971 - Akorn Ophthalmics is founded in Albita Springs, Louisiana, 1992 - Akorn acquires Taylor Pharmacal, 1996 - Akorn acquires Pasadena Research Laboratories and its injectable products, 1998 - Akorn acquires Advanced Remedies Inc. in Somerset, NJ, 2007 - Akorn is listed on the NASDAQ exchange, 2011 - Akorn acquires Advanced Vision Research, 2012 - Akorn acquires manufacturing assets in India from Kilitch Drugs, 2013 - Akorn enters into an agreement to acquire Hi-Tech Pharmacal in Amityville, NY

From AKRX 2013 Annual Report:


Revenue in thousands, Gross Margin Percentage, Akorn Closing Stock Price (Nasdaq: AKRX), Annual Units Produced (in millions), Filed ANDAs (Product Count & Market Value), ANDA Filings Per Year